会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • OVR232V3 ANTIBODY COMPOSITIONS AND METHODS OF USE
    • OVR232V3抗体组合物及其使用方法
    • WO2007016590A2
    • 2007-02-08
    • PCT/US2006/029995
    • 2006-07-31
    • DIADEXUS, INC.LIU, Shu-HuiPAPKOFF, Jackie
    • LIU, Shu-HuiPAPKOFF, Jackie
    • A61K39/395
    • C07K16/30A61K2039/505C07K2317/73C07K2317/77G01N33/5011G01N33/56966G01N33/57419G01N33/57423G01N33/57434G01N33/57449G01N33/57492
    • The invention provides isolated anti-ovarian, colon, prostate, or lung cancer antigen (Ovr232v3) antibodies that bind to Ovr232v3 on a mammalian cell. The invention also encompasses compositions containing an anti-Ovr232v3 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Ovr232v3 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Ovr232v3 antibodies. The invention encompasses a method of producing the anti-Ovr232v3 antibodies. Other aspects of the invention are a method of killing an Ovr232v3-expressing cancer cell via contacting the cancer cell with an anti-Ovr232v3 antibody and a method of alleviating or treating an Ovr232v3 -expressing cancer in a mammal via administering a therapeutically effective amount of the anti-Ovr232v3 antibody to the mammal.
    • 本发明提供了结合哺乳动物细胞上的Ovr232v3的分离的抗卵巢,结肠,前列腺或肺癌抗原(Ovr232v3)抗体。 本发明还包括含有抗Ovr232v3抗体和载体的组合物。 这些组合物可以在制品或试剂盒中提供。 本发明的另一方面是编码抗Ovr232v3抗体的分离的核酸,以及包含分离的核酸的表达载体。 还提供产生抗Ovr232v3抗体的细胞。 本发明包括产生抗Ovr232v3抗体的方法。 本发明的其它方面是通过使癌细胞与抗Ovr232v3抗体接触来杀死表达Ovr232v3的癌细胞的方法,以及通过施用治疗有效量的哺乳动物缓解或治疗表达Ovr232v3的癌症的方法 抗Ovr232v3抗体。